BFLY vs COR vs ELAN Stock Comparison

Butterfly Network, Cencora and Elanco Animal Health Prices as of Nov 13, 2026 Peers: Industry group
BFLY Butterfly Network, Inc.
$6.09 -19.9% 1M +194.2% 1Y
Market cap
$1.53B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
2 wins
COR Cencora, Inc.
$359.02 +6.8% 1M -1.8% 1Y
Market cap
$69.10B
P/E
22.6x
Revenue (TTM)
$337.40B
Div. yield
–
Drug Distribution Healthcare
4 wins

Head to Head

10 decided of 12

Cencora leads on 4 of the 12 questions below (Cencora 4, Elanco Animal Health 4, Butterfly Network 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYCORELANLeader
Larger companyMarket capitalisation $1.53B $69.10B $13.25B COR
Cheaper on earningsLower P/E, profitable companies only -28.5x 22.6x -90.2x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 18.8x 23.7x COR
Faster revenue growthRevenue growth, trailing twelve months +39.4% +5.0% +12.1% BFLY
More profitableNet margin, trailing twelve months -43.6% — -2.9% ELAN
Better return on capitalReturn on invested capital -30.5% — 6.9% ELAN
Less leveragedLower net debt / EBITDA 2.3x — 2.3x ELAN
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +194.2% -1.8% +21.8% BFLY
Better 5-year returnAnnualised price return, 5 years -6.7%/yr +23.4%/yr -4.1%/yr COR
Less volatileAnnualised volatility, 1 year 112.2% 33.4% 43.4% COR
Higher overall scoreMean of the five percentile scores vs peers 53/100 56/100 69/100 ELAN

Percentile Scorecard

BFLYCORELAN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYCORELAN
Valuation 31 #167 of 243 54 #13 of 27 92 #52 of 660
Growth 88 #28 of 228 64 #10 of 26 67 #208 of 619
Profitability 39 #137 of 222 64 #10 of 26 85 #90 of 595
Financial Health 68 #81 of 248 – 31 #473 of 683
Shareholder Returns 41 #94 of 158 41 #11 of 18 73 #126 of 459
Overall 53 56 69
  • BFLY ranked among 252 companies in Medical Devices and Diagnostics
  • COR ranked among 27 companies in Healthcare Payers and Distributors
  • ELAN ranked among 695 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYCORELANSPY
1 month -19.9%+6.8%+18.8% -2.0%
3 months -31.1%+14.4%+13.2% -2.8%
6 months +59.0%+39.3%+34.9% +2.0%
Year to date +60.3%+6.3%+18.4% +10.6%
1 year +194.2%-1.8%+21.8% +12.2%
3 years +399.2%+84.7%+136.2% +68.1%
3 years, per year +71.0%+22.7%+33.2% +18.9%
5 years -29.2%+186.4%-18.9% +61.4%
5 years, per year -6.7%+23.4%-4.1% +10.1%
10 years —+354.9%— +248.5%
10 years, per year —+16.4%— +13.3%

Risk

MeasureBFLYCORELANSPY
Volatility, 1Y 112.2%33.4%43.4% 13.6%
Downside volatility, 1Y 93.8%40.0%43.7% 13.9%
Beta vs S&P 500, 1Y 2.990.051.32 1.00
Return / volatility, 1Y 1.73-0.050.50 0.90
Max drawdown, 5Y -92.2%-32.6%-75.0% -25.4%
From 52-week high -38.7%-4.2%-0.2% -3.2%
52-week high $9.94$374.75$26.84 $779.14
52-week low $1.97$252.74$19.80 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYCORELAN
P/E now vs peer median -30.2xmedian 26.5x 22.6xmedian 25.2x -91.1xmedian 17.0x
P/S now vs peer median 13.2xmedian 2.7x 0.2xmedian 0.4x 2.6xmedian 8.4x
EV/EBITDA now vs peer median -29.5xmedian 18.4x —median 14.5x 11.8xmedian 14.6x
P/FCF now vs peer median -58.9xmedian 25.4x 14.5xmedian 16.5x 32.8xmedian 19.0x
P/B now vs peer median 8.8xmedian 2.5x 18.6xmedian 2.7x 2.0xmedian 2.0x
PEG now vs peer median -1.00median 0.98 —median 1.72 -1.82median 0.43

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYCORELAN
Revenue $123.25M $337.40B $5.15B
Gross profit $86.60M $13.87B $2.89B
Operating income -$57.83M $3.93B $720.00M
Net income -$53.69M $3.51B -$147.00M
Free cash flow -$27.55M – $408.00M
R&D $39.57M – $381.00M
EPS (diluted) $-0.20 – $-0.29
Cash & equivalents $122.30M $4.88B $465.00M
Total debt $2.92M – $3.71B
Shares (diluted) 266.50M 193.94M 506.50M
Enterprise value $992.96M $69.10B $11.29B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYCORELAN
P/E -30.2x 22.6x -91.1x
P/FCF -58.9x 14.5x 32.8x
P/Operating cash flow -69.4x 14.3x 21.8x
P/S 13.2x 0.2x 2.6x
P/B 8.8x 18.6x 2.0x
P/Tangible book 9.1x 18.6x 3.7x
EV/EBITDA -29.5x – 11.8x
EV/EBIT -26.0x – 23.1x
EV/Revenue 12.2x 0.2x 3.2x
EV/FCF -54.6x – 40.8x
EV/Operating cash flow -64.3x 14.3x 27.1x
PEG (3Y EPS CAGR) -1.00 – -1.82

Growth

14 metrics
MetricBFLYCORELAN
Revenue growth (1Y) 39.4% 5.0% 12.1%
Revenue CAGR (3Y) 21.7% 8.8% 5.6%
Gross profit growth (1Y) 126.4% 20.8% 14.6%
Gross profit CAGR (3Y) 30.5% 15.7% 4.9%
Operating income growth (1Y) 33.5% 49.5% 20.6%
Operating income CAGR (3Y) 26.9% 18.9% 41.2%
Net income growth (1Y) 32.8% 124.0% -508.3%
Net income CAGR (3Y) 24.2% 26.3% 49.5%
EPS growth (1Y) 36.4% – -500.5%
EPS CAGR (3Y) 30.4% – 50.0%
Operating cash flow growth (1Y) 5.8% 23.6% -2.4%
Operating cash flow CAGR (3Y) 41.1% 7.0% 69.1%
Free cash flow growth (1Y) -0.1% – 10.9%
Free cash flow CAGR (3Y) 38.8% – 117.8%

Profitability

14 metrics
MetricBFLYCORELAN
Gross margin 70.3% – 56.2%
EBITDA margin -41.4% – 27.5%
Operating margin -46.9% – 14.0%
Pretax margin -43.5% – -1.8%
Net margin -43.6% – -2.9%
FCF margin -22.4% – 7.9%
Operating cash flow margin -19.0% 1.4% 11.9%
Return on equity -28.7% 101.2% -2.2%
Return on assets -18.8% 4.1% -1.1%
Return on invested capital -30.5% – 6.9%
Return on capital employed -26.6% – 6.2%
Asset turnover 0.4x 3.9x 0.4x
Cash conversion (OCF / net income) 0.4x 1.4x -4.2x
Stock comp / revenue 20.8% – 1.5%

Financial Health

11 metrics
MetricBFLYCORELAN
Debt / assets 1.0% – 27.8%
Debt / equity 0.0x – 0.6x
Net debt / EBITDA 2.3x – 2.3x
Debt / FCF -0.1x – 9.1x
Liabilities / assets 36.0% – 50.3%
Equity / assets 64.0% 4.2% 49.7%
Interest coverage -46.8x – 2.8x
Current ratio 3.6x 0.9x 2.1x
Quick ratio 2.3x – 0.9x
Cash ratio 1.8x – 0.3x
Altman Z-score 5.44 – 1.72

Shareholder Returns

7 metrics
MetricBFLYCORELAN
Dividend yield – 0.9% –
Net buyback yield -0.5% – -0.3%
Shareholder yield -0.5% 0.9% -0.3%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYCORELAN
Forward P/E – 18.8xFY2027 23.7xFY2026
EPS, next fiscal year $-0.06FY2026 $19.07FY2027 $1.13FY2026
EPS growth, next FY – +6.1%FY2027 +20.2%FY2026
EPS growth, the year after – +17.4% +22.1%
Revenue, next fiscal year $117.62MFY2026 $328.27BFY2027 $4.82BFY2026
Revenue growth, next FY +20.5%FY2026 -2.7%FY2027 +2.4%FY2026
Revenue growth, the year after +22.7% +19.1% +19.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYCORELAN
Held by institutions 58.4% 94.7% 100.0%
Institutions holding 248 1,345 526
Change in shares held, QoQ +13.9% +15.7% +4.4%
Institutions buying 144 542 246
Institutions selling 59 612 211
Buyers to sellers 2.44 0.89 1.17

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYCORELAN
BFLY 1.00 0.00 0.17
COR 0.00 1.00 -0.03
ELAN 0.17 -0.03 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, COR and ELAN?

Cencora (COR) is the largest by market capitalisation: Butterfly Network (BFLY) $1.53B, Cencora (COR) $69.10B, Elanco Animal Health (ELAN) $13.25B.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +39.4%, Cencora (COR) +5.0%, Elanco Animal Health (ELAN) +12.1%.

Which company is more profitable?

Elanco Animal Health (ELAN) has the highest net margin (Butterfly Network (BFLY) -43.6%, Elanco Animal Health (ELAN) -2.9%). On return on invested capital, Elanco Animal Health (ELAN) leads (Butterfly Network (BFLY) -30.5%, Elanco Animal Health (ELAN) 6.9%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +194.2%, Cencora (COR) -1.8%, Elanco Animal Health (ELAN) +21.8%. Over five years, Cencora (COR) compounded fastest (Butterfly Network (BFLY) -6.7%/yr, Cencora (COR) +23.4%/yr, Elanco Animal Health (ELAN) -4.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Cencora (COR) has been the steadiest (Butterfly Network (BFLY) 112.2%, Cencora (COR) 33.4%, Elanco Animal Health (ELAN) 43.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, COR and ELAN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cencora (COR) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.